Phenotypic features of first-generation transgenic goats for human granulocyte-colony stimulation factor production in milk

Human granulocyte-colony stimulating factor (hG-CSF) is a hematopoietic growth factor used in neutropenic patients. It is produced in transgenic bacteria or cultured mammalian cells. As an alternative, we now show that hG-CSF can be expressed in the mammary gland of first-generation (F1) transgenic...

Full description

Saved in:
Bibliographic Details
Published inBiotechnology letters Vol. 36; no. 11; pp. 2155 - 2162
Main Authors Batista, Ribrio I.T.P, Melo, Carlos H.S, Souza-Fabjan, Joanna M.G, Teixeira, Dárcio I.A, Melo, Luciana M, Freitas, Vicente J.F
Format Journal Article
LanguageEnglish
Published Dordrecht Springer-Verlag 01.11.2014
Springer Netherlands
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human granulocyte-colony stimulating factor (hG-CSF) is a hematopoietic growth factor used in neutropenic patients. It is produced in transgenic bacteria or cultured mammalian cells. As an alternative, we now show that hG-CSF can be expressed in the mammary gland of first-generation (F1) transgenic goats during induced lactation. Despite lower milk production, transgenic females presented a similar milk composition (fat, protein and lactose) when compared to non-transgenic (p > 0.05) ones. The mean concentration (±SD) of recombinant hG-CSF in milk during lactation was 360 ± 178 µg ml⁻¹. All clinical parameters, as well as kidney and liver function, indicated that F1 transgenic goats were healthy. Additionally, no ectopic hG-CSF expression was detected in studied tissues of F1 transgenic males. Thus, F1 hG-CSF-transgenic goats can express the recombinant protein in milk at quantities compatible with their use as bioreactors in a commercial-scale protein-production program.
Bibliography:http://dx.doi.org/10.1007/s10529-014-1588-0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0141-5492
1573-6776
DOI:10.1007/s10529-014-1588-0